Not Yet RecruitingNot Applicable

Dome-Only Aneurysm Coiling in Severe Aneurysmal Subarachnoid Hemorrhage

30 participantsStarted 2026-01

Plain-language summary

The DOME study is a clinical trial exploring a new treatment approach for patients who suffered a severe brain bleed due to an aneurysm.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years or older * CT confirmed aSAH with an angiographically detected aneurysm * World Federation of Neurological Sciences (WFNS) aSAH grade 3-5 aneurysm * LAR available and gives consent within 72 hours after the onset of aSAH (or last known normal Exclusion Criteria: * Patients whose aneurysm judged appropriate for balloon-assisted coiling * Patients whose aneurysm is bleeding from the "neck" * Patients who are clinically judged to suffer imminent death within 24 hours. * Pregnancy or positive urine pregnancy test

What they're measuring

Re-rupture incidence

Timeframe: From procedure to 90-days post procedure.

Trial details

NCT IDNCT07250958

SponsorUniversity of Louisville

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-01

View on ClinicalTrials.gov More Aneurysmal Subarachnoid Hemorrhage trials